Capital Stock (Tables)
|
6 Months Ended |
Mar. 31, 2026 |
| Capital Stock [Abstract] |
|
| Schedule of Outstanding Warrants |
A continuity schedule of outstanding
warrants at September 30, 2025 and March 31, 2026, and the changes during the periods, is as follows:
| | |
Number of Warrants | | |
Weighted Average Exercise Price | |
| | |
| | |
US$ | |
| Balance, September 30, 2024 | |
| 122,668 | | |
| 102.08 | |
| Granted | |
| 859,589 | | |
| 7.75 | |
| Exercised | |
| - | | |
| - | |
| Balance, September 30, 2025 | |
| 982,257 | | |
| 19.53 | |
| Forfeited | |
| (97,668 | ) | |
| 120 | |
| Balance, March 31, 2026 | |
| 884,589 | | |
| 8.44 | |
|
| Schedule of Warrants Outstanding and Exercisable |
A summary of warrants outstanding
and exercisable at September 30, 2025:
| | | Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | | | | | | US$ | | | | | | Grant date | | | | | | | | | | | March 29, 2021 | | | 97,668 | | | | 120 | | | | 0.49 | | | January 8, 2024 | | | 25,000 | | | | 32 | | | | 3.27 | | | May 27, 2025 | | | 843,750 | | | | 7.68 | | | | 0.65 | | | August 26, 2025 | | | 15,839 | | | | 11.68 | | | | 4.9 | |
A summary of warrants
outstanding and exercisable at March 31, 2026:
| | | Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | | | | | | US$ | | | | | | Grant date | | | | | | | | | | | January 8, 2024 | | | 25,000 | | | | 32.00 | | | | 2.77 | | | May 27, 2025 | | | 843,750 | | | | 7.68 | | | | 0.15 | | | August 26, 2025 | | | 15,839 | | | | 11.68 | | | | 4.40 | | A summary of stock options
outstanding and exercisable at September 30, 2025:
| | | Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | | | | | | US$ | | | | | | Grant date | | | | | | | | | | | November 1, 2021 | | | 22,813 | | | | 65.60 | | | | 6.08 | | | December 30, 2022 | | | 5,625 | | | | 35.36 | | | | 7.25 | | | October 19, 2023 | | | 63,359 | | | | 18.56 | | | | 8.08 | | | August 6, 2025 | | | 56,250 | | | | 8.59 | | | | 9.83 | | A summary of stock options
outstanding and exercisable at March 31, 2026:
| | | Exercisable | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | | | | | | US$ | | | | | | Grant date | | | | | | | | | | | November 1, 2021 | | | 22,813 | | | | 65.60 | | | | 5.58 | | | December 30, 2022 | | | 5,625 | | | | 35.36 | | | | 6.75 | | | October 19, 2023 | | | 63,828 | | | | 18.56 | | | | 7.58 | | | August 6, 2025 | | | 60,000 | | | | 8.59 | | | | 9.33 | | | October 14, 2025 | | | 149,219 | | | | 7.17 | | | | 9.54 | |
|
| Schedule of Outstanding Stock Options |
A continuity schedule of outstanding
stock options at September 30, 2025 and March 31, 2026, and the changes during the periods, is as follows:
| | |
Number of Stock Options | | |
Weighted Average Exercise Price | |
| | |
| | |
US$ | |
| Balance, September 30, 2024 | |
| 92,813 | | |
| 31.14 | |
| Granted | |
| 64,375 | | |
| 8.59 | |
| Balance, September 30, 2025 | |
| 157,188 | | |
| 21.91 | |
| Granted | |
| 160,938 | | |
| 7.17 | |
| Balance, March 31, 2026 | |
| 318,125 | | |
| 14.45 | |
|
| Schedule of Outstanding Unvested Stock Options |
A continuity schedule of outstanding
unvested stock options at September 30, 2025 and March 31, 2026, and the changes during the periods, is as follows:
| | |
Number of Unvested Stock Options | | |
Weighted Average Grant Date Fair Value | |
| | |
| | |
US$ | |
| Balance, September 30, 2024 | |
| 17,344 | | |
| 17.60 | |
| Granted | |
| 64,375 | | |
| 7.68 | |
| Vested | |
| (72,578 | ) | |
| 10.88 | |
| Forfeited | |
| - | | |
| - | |
| Balance, September 30, 2025 | |
| 9,141 | | |
| 9.70 | |
| Granted | |
| 160,938 | | |
| 7.17 | |
| Vested | |
| (153,438 | ) | |
| 7.24 | |
| Forfeited | |
| - | | |
| - | |
| Balance, March 31, 2026 | |
| 16,641 | | |
| 7.92 | |
|